Ethris Alternatives & Competitors
12 companies similar to Ethris — Clinical stage biotech company focused on development of disruptive mRNA therape...
Companies similar to Ethris
SonoThera
SonoThera is developing ultrasound-mediated nonviral genetic therapies.
Arrakis Therapeutics
Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) therapies to...
Interius BioTherapeutics
Interius is developing new ways to engineer cells inside the human body, right where they...
Rival Readout
Competing with Ethris? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Kernal Biologics
KernalBio creates mRNA therapies that instruct specific cells on how to make their own med...
Dyno Therapeutics
We build AI-powered gene therapies.
miRecule, Inc.
RNA Therapeutics
REGENXBIO
Seeking to improve lives through the curative potential of gene therapy.
ROME Therapeutics
Harnessing the power of the repeatome to develop a new class of therapies for cancer and a...
Versameb AG
The next generation of RNA therapeutics
RHEACELL GmbH & Co. KG
Innovative Stem Cell Therapies Experts from Heidelberg, Germany
Aera Therapeutics
Enabling the next generation of transformative genetic medicines
About Ethris
Ethris, founded in 2009 and headquartered in Germany, is a pioneering player in the Biopharma, Biotechnology, and Pharmaceutical industries, notably also making strides in Clean Energy. The company is distinguished by its innovative approach to using its proprietary messenger RNA technology platform to develop therapeu...
Development of mRNA therapeutics, Innovative RNA delivery platforms, Collaborative partnerships and licensing, Clinical pipeline advancement
Pharmaceutical companies, Biotech firms, Healthcare providers, Patients with respiratory and genetic disorders
Messenger RNA Technology, Therapeutic Proteins, Transcript Therapies, Integrated Platform, Gene Therapy, Drug Development, Cell Therapy, Tissue Engineering, Biopharmaceuticals
B2B, B2C, B2B2C
Licensing, Project Based, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Ethris: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Ethris on 11 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.